BOSTON SCIENTIFIC CORP — Director's Dealing 2018

Apr 3, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-04-01

Reporting Person: Eddy Jodi Euerle (SVP and CIO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14203.0000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Deferred Stock Units	$	2019-01-02	Common Stock (2099.0000)		Direct
Deferred Stock Units	$	2021-02-22	Common Stock (5214.0000)		Direct
Deferred Stock Units	$	2020-02-23	Common Stock (2208.0000)		Direct
Deferred Stock Units	$	2019-02-24	Common Stock (230.0000)		Direct
Deferred Stock Units	$	2022-02-28	Common Stock (5703.0000)		Direct
Stock Option (Right to Buy)	$13.0800	2024-02-24	Common Stock (3000.0000)		Direct
Stock Option (Right to Buy)	$16.3100	2025-02-23	Common Stock (16697.0000)		Direct
Stock Option (Right to Buy)	$17.2600	2026-02-22	Common Stock (27675.0000)		Direct
Stock Option (Right to Buy)	$24.5500	2027-02-28	Common Stock (25252.0000)		Direct

Footnotes

F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on January 2, 2015, the first anniversary of the date of grant.

F3: This amount represents the unvested portion of DSUs awarded on January 2, 2014, which will continue to vest in one remaining installment on the anniversary of the date of grant.

F4: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F5: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

F6: This amount represents the unvested portion of DSUs awarded on February 22, 2016, which will continue to vest in three remaining installments on the anniversary of the date of grant.

F7: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

F8: This amount represents the unvested portion of DSUs awarded on February 23, 2015, which will continue to vest in two remaining installments on the anniversary of the date of grant.

F9: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

F10: This amount represents the unvested portion of DSUs awarded on February 24, 2014, which will continue to vest in one remaining installment on the anniversary of the date of grant.

F11: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

F12: This amount represents the unvested portion of DSUs awarded on February 28, 2017, which will continue to vest in four remaining installments on the anniversary of the date of grant.

F13: Grant to the reporting person of an option to purchase a 3,000 shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.

F14: Grant to the reporting person of an option to purchase a 16,697 shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

F15: Grant to the reporting person of an option to purchase a 27,675 shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.

F16: Grant to the reporting person of an option to purchase a 25,252 shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.